TABLE I.
Search strategies
| Database | Set | History |
|---|---|---|
| MEDLINE, 1946 to Week 1, May 2017 | ||
| 1 | fatigue/ or (fatigue or fatigued).ti,ab,kf. | |
| 2 | exp neoplasms/ or stem cell transplantation/ or cord blood stem cell transplantation/ or hematopoietic stem cell transplantation/ or mesenchymal stem cell transplantation/ or peripheral blood stem cell transplantation/ or bone marrow transplantation/ or transplantation, autologous/ or exp antineoplastic agents/ or chemotherap*.mp. or exp antineoplastic protocols/ or (cancer* or neoplas* or oncolog* or tumor* or tumour* or transplant* or chemotherap*).mp. | |
| 3 | randomized controlled trial.pt. | |
| 4 | controlled clinical trial.pt. | |
| 5 | randomized.ab. | |
| 6 | randomised.ab. | |
| 7 | randomly.ab. | |
| 8 | (trial or trials).ti,ab. | |
| 9 | or/3–8 | |
| 10 | 1 and 2 and 9 | |
| 11 | limit 10 to yr=“1980 -Current” | |
| 12 | limit 11 to humans | |
| MEDLINE in-process and other non-indexed citations, 10 May 2017 | ||
| 1 | (fatigue or fatigued).ti,ab,kw. | |
| 2 | (neoplasm* or neoplas* or cancer* or oncolog* or tumor* or tumour* or transplant*).mp. | |
| 3 | (hsct or bmt or chemotherap* or (antineoplas* adj2 protocol*) or (antineoplas* adj2 (agent* or drug or treatment*))).mp. | |
| 4 | or/2–3 | |
| 5 | (RCT or RCTS).ti,ab. | |
| 6 | randomized.ab. | |
| 7 | randomised.ab. | |
| 8 | randomly.ab. | |
| 9 | (trial or trials).ti,ab. | |
| 10 | or/5–9 | |
| 11 | 1 and 4 and 10 | |
| EMBASE, 1980 to Week 19, 2017 | ||
| 1 | *fatigue/ or (fatigue or fatigued).ti,ab,kw. | |
| 2 | exp neoplasm/ or exp antineoplastic agent/ or (antineoplas* adj2 protocol*).mp. | |
| 3 | (neoplas* or cancer* or oncolog* or tumor* or tumour* or transplant* or chemotherap*).mp. | |
| 4 | or/2–3 | |
| 5 | 1 and 4 | |
| 6 | cancer fatigue/ or (cancer* adj2 fatigue*).ti,ab,kw. | |
| 7 | 5 or 6 | |
| 8 | limit 7 to (randomized controlled trial or controlled clinical trial) | |
| 9 | (randomized or randomised or randomly).ab. | |
| 10 | (trial or trials).ti,ab. | |
| 11 | or/9–10 | |
| 12 | 8 or (7 and 11) | |
| 13 | limit 12 to conference abstract | |
| 14 | 12 Not 13 | |
| 15 | limit 14 to human | |
| PsycINFO, 1806 to Week 1, May 2017 | ||
| 1 | fatigue/ or (fatigue or fatigued).ti,ab,id. | |
| 2 | exp neoplasms/ or chemotherapy/ or exp antineoplastic drugs/ | |
| 3 | ((“stem cell*” or “stem-cell*” or “cord blood” or “bone marrowor autologous”) adj3 transplant*).mp. | |
| 4 | (cancer* or neoplas* or oncolog* or tumor* or tumour* or transplant* or chemotherap*).mp. | |
| 5 | or/2–4 | |
| 6 | 1 and 5 | |
| 7 | limit 6 to “0300 clinical trial” | |
| 8 | randomized.ab. | |
| 9 | randomised.ab. | |
| 10 | randomly.ab. | |
| 11 | (trial or trials).ti,ab. | |
| 12 | (RCT or CCT).ti,ab. | |
| 13 | clinical trials/ | |
| 14 | or/8–13 | |
| 15 | 7 or (6 and 14) | |
| 16 | limit 15 to yr=“1980 -Current” | |
| Cochrane Central Register of Controlled Trials, Issue 5, 12 May 2017 | ||
| 1 | MeSH descriptor: [Fatigue] this term only | |
| 2 | (fatigue or fatigued):ti,ab | |
| 3 | (or #1-#2) | |
| 4 | MeSH descriptor: [Neoplasms] explode all trees | |
| 5 | MeSH descriptor: [Antineoplastic Agents] explode all trees | |
| 6 | MeSH descriptor: [Antineoplastic Protocols] explode all trees | |
| 7 | (neoplas* or cancer* or oncolog* or tumor* or tumour* or transplant* or chemotherap*):ti,ab | |
| 8 | (or #4-#7) | |
| 9 | #3 and #8 Publication Year from 1980 to 2017 | |
| CINAHL, 1983 to 11 May 2017 | ||
| 1 | (MH “Cancer Fatigue”) OR (MH “Fatigue”) | |
| 2 | TI (fatigue OR fatigued) OR AB (fatigue OR fatigued) | |
| 3 | 1 OR 2 | |
| 4 | (MH “Neoplasms+”) OR (MH “Antineoplastic Agents+”) OR (MH “Antineoplastics, ImmuNosuppressives”) | |
| 5 | TX (antineoplastic N2 protocol*) | |
| 6 | (MH “ImmuNocompromised Host”) | |
| 7 | 4 OR 5 OR 6 | |
| 8 | 3 AND 7 | |
| 9 | (MH “Double-Blind Studies”) OR (MH “Randomized Controlled Trials”) OR (MH “Triple-Blind Studies”) OR (MH “Single-Blind Studies”) | |
| 10 | AB randomized or randomised or randomly or trial or trials | |
| 11 | 9 OR 10 | |
| 12 | 8 AND 11 | |